Trending News – July 28, 2022

Play this Episode

In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49).


Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal health, digital health, Medicaid, prescription drugs, Life Sciences

Source Links:

· H1 2022 digital health funding: Two sides to every correction | Rock Health

· https://www.fiercehealthcare.com/digital-health/market-downturn-dampens-digital-health-funding-ma-2022-here-are-sectors-raked-most 

· https://www.npr.org/sections/health-shots/2022/07/15/1111316589/988-suicide-hotline-number 

· https://apnews.com/article/abortion-bills-house-vote-fc24d99f184d7aeec4926a6520311da5 

· Characteristics of U.S. Abortion Patients in 2014 and Changes Since 2008 | Guttmacher Institute

· https://www.advisory.com/blog/2022/07/abortion-restrictions?utm_source=public_db&utm_medium=email&utm_campaign=2022jul13&utm_content=public_headline_public_blog_x_x_x&elq_cid=4793240&x_id= 

· https://thehill.com/homenews/senate/3559360-gop-senator-blocks-bill-to-protect-interstate-travel-for-abortion/ 

· https://www.hrsa.gov/about/organization/bureaus/opae/hrsa-information-quality-guidelines/agency-mission 

· Merck joins other drugmakers in cutting off sales to 340B contract pharmacies | Fierce Healthcare

· https://www.fiercehealthcare.com/providers/merck-sues-hhs-avoid-fine-over-340b-contract-pharmacy-restrictions 


For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.


Mindy McGrath, Healthcare Industry Advisor

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Want to learn more? Get in Touch!

Contact our team to learn more about how we can help your needs.

Let's Talk

Send us a message and we'll get back to you shortly.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.